Using specific molecules to control dental stem cells for tissue repair
Co-opting Lef-1 and miR-26b activities to regulate dental stem cells and their progeny
This study is looking at how specific molecules can help dental stem cells heal and regenerate damaged tissues, with the hope of finding new ways to improve treatments for patients needing tissue repair or artificial organs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-10893989 on NIH RePORTER |
What this research studies
This research investigates how certain molecules, specifically miR-26b and Lef-1, can influence dental stem cells and their ability to regenerate damaged tissues. By understanding the roles of these molecules, the research aims to develop methods to manipulate stem cell behavior, which could lead to advancements in creating artificial organs and repairing tissues. The approach involves studying the mechanisms of stem cell differentiation and how these processes can be harnessed for therapeutic purposes. Patients may benefit from new treatments that enhance tissue regeneration and repair.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that affect dental tissues or require regenerative therapies.
Not a fit: Patients with conditions unrelated to dental tissue or those who do not require regenerative treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies for repairing damaged tissues and organs, significantly improving patient outcomes.
How similar studies have performed: Other research has shown promise in using similar molecular approaches to manipulate stem cell behavior, indicating potential for success in this area.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Amendt, Brad a — University of Iowa
- Study coordinator: Amendt, Brad a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.